DexCom, Inc. (NASDAQ:DXCM) Files An 8-K Other Events
Item8.01
| Other Events. |
On May8, 2017, DexCom, Inc. (DexCom)
issued a press release announcing the pricing of its offering of
$350million aggregate principal amount of 0.75% Convertible
Senior Notes due 2022 (the Notes) in a
private placement to qualified institutional buyers to Rule 144A
under the Securities Act of 1933, as amended. The size of the
offering was increased from the previously announced $300 million
in aggregate principal amount. DexCom also granted the initial
purchasers of the Notes an option to purchase up to an additional
$50million aggregate principal amount of Notes solely to cover
over-allotments, if any. A copy of the press release announcing
the pricing of the Notes is attached hereto as Exhibit 99.1 and
is incorporated herein by reference.
| Item9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
|
Exhibit Number |
Description |
|
| 99.1 |
Press release dated May8, 2017 announcing the pricing of the Notes. |
About DexCom, Inc. (NASDAQ:DXCM)
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products include SEVEN PLUS, DexCom G4, DexCom G4 PLATINUM, DexCom Share System and DexCom G5 Mobile. It had received Conformite Europeene Marking (CE Mark) approval for its fourth generation continuous glucose monitoring system, the DexCom G4 system, enabling commercialization of the DexCom G4 system. DexCom SHARE enables users of its G4 PLATINUM System to have their sensor glucose information remotely monitored by their family or friends. The G4 PLATINUM Receiver with Share uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient’s receiver and a mobile application on the patient’s iPhone to transmit glucose information. DexCom, Inc. (NASDAQ:DXCM) Recent Trading Information
DexCom, Inc. (NASDAQ:DXCM) closed its last trading session down -2.81 at 73.40 with 2,173,518 shares trading hands.